Market Overview:
The global Josamycin drugs market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of infectious diseases, rising demand for antibiotics, and growing awareness about antibiotic resistance. By type, the Josamycin tablets segment is expected to account for the largest share of the global Josamycin drugs market in 2018. By application, the hospital pharmacy segment is expected to account for the largest share of the global Josamycin drugs market in 2018.
Product Definition:
A macrolide antibiotic isolated from Streptomyces josamycini; used to treat respiratory and skin infections.
Josamycin Tablets:
Josamycin is a semi-synthetic antibiotic drug, which belongs to the class of drugs called as lipoglycopeptides. It was first discovered in soil bacteria and later on found to be effective against gram-positive and gram-negative bacteria. The drug has been approved by the U.
Josamycin Propionate Granules:
Josamycin propionate granules are the basic drug ingredient for josamycin antibiotics. It is a white to slightly yellowish powder, which is insoluble in water and very soluble in alcohol. The chemical structure of the product consists of a six-membered lactam ring with one amide group (C6-N) and two carboxyl groups (C8-O and C4-H).
Application Insights:
Based on the application, the market is segmented into hospital pharmacy, retail drug stores and others. The hospital pharmacy segment dominated the global market in 2017. This can be attributed to factors such as high usage rate of antibiotics in hospitals and rising awareness about antibiotic consumption among patients. Furthermore, increasing government initiatives for reducing healthcare expenditure are expected to have a positive impact on industry growth over the forecast period.
The retail drug stores are anticipated to witness significant growth over the forecast period owing to increasing consumer awareness regarding access of quality medicines at affordable prices through local pharmacies. Moreover, growing penetration of e-pharmacies that offer same day delivery services is further expected to drive demand for josamycin drugs from 2018 - 2030 ¢â‚¬â€œ especially across emerging countries where online pharmacies operate without license or authentication requirements under regulatory supervision (such as India).
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period owing to favorable reimbursement policies, increasing healthcare expenditure, and rising awareness among patients. Moreover, new product launches are also expected to contribute towards regional growth over the next eight years.
Asia Pacific is anticipated to witness lucrative CAGR over the forecast period due to factors such as improving healthcare infrastructure and growing patient awareness regarding available treatment options. Furthermore, government initiatives for improving public health may also boost revenue generation in this region during the same period.
Growth Factors:
- Increasing incidence of infectious diseases: The increasing incidence of infectious diseases is one of the key growth drivers for the Josamycin Drugs market. Infectious diseases are caused by pathogenic microorganisms such as bacteria, viruses, and parasites. These infections can cause a wide range of symptoms, depending on the site and severity of infection. The global burden of infectious diseases is high and continues to increase every year. According to the World Health Organization (WHO), there were about 17 million deaths due to infectious diseases in 2015, accounting for approximately 60% of all global deaths. This high burden is attributed to several factors such as population growth and aging, increased travel and trade, changes in lifestyle and eating habits, lack of clean water and sanitation facilities, inadequate health care infrastructure, emergence or re-emergence of pathogens etc
- Rising prevalence Of Antimicrobial Resistance: Antimicrobial resistance (AMR) is another major factor that drives the demand for Josamycin Drugs market globally . AMR occurs when microorganisms (such as bacteria) change so that antibiotics no longer work against them . It threatens human health worldwide by making common infections like pneumonia , tuberculosis , gonorrhea etc., difficult or impossible to treat . According to a recent study published by Review on Antibiotic Resistance , it was estimated that antimicrobial resistance will cause 10 million deaths annually by 2050 if no action is taken . This growing threat has led governments across the globe towards taking initiatives for containment AMR through
Scope Of The Report
Report Attributes
Report Details
Report Title
Josamycin Drugs Market Research Report
By Type
Josamycin Tablets, Josamycin Propionate Granules
By Application
Hospital Pharmacy, Retail Drug Stores
By Companies
Astellas Pharma Inc., Guanghua Pharmaceutical, Minsheng Pharmaceutical, Suzhou No.1 Pharm, Southwest Pharmaceutical, Wanbang Biopharmaceuticals, Bayer
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
156
Number of Tables & Figures
110
Customization Available
Yes, the report can be customized as per your need.
Global Josamycin Drugs Market Report Segments:
The global Josamycin Drugs market is segmented on the basis of:
Types
Josamycin Tablets, Josamycin Propionate Granules
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital Pharmacy, Retail Drug Stores
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Astellas Pharma Inc.
- Guanghua Pharmaceutical
- Minsheng Pharmaceutical
- Suzhou No.1 Pharm
- Southwest Pharmaceutical
- Wanbang Biopharmaceuticals
- Bayer
Highlights of The Josamycin Drugs Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Josamycin Tablets
- Josamycin Propionate Granules
- By Application:
- Hospital Pharmacy
- Retail Drug Stores
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Josamycin Drugs Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Josamycin drugs are antibiotics that are used to treat a variety of infections. These drugs work by killing the bacteria responsible for the infection.
Some of the key players operating in the josamycin drugs market are Astellas Pharma Inc., Guanghua Pharmaceutical, Minsheng Pharmaceutical, Suzhou No.1 Pharm, Southwest Pharmaceutical, Wanbang Biopharmaceuticals, Bayer.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Josamycin Drugs Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 Josamycin Drugs Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 Josamycin Drugs Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the Josamycin Drugs Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global Josamycin Drugs Market Size & Forecast, 2020-2028 4.5.1 Josamycin Drugs Market Size and Y-o-Y Growth 4.5.2 Josamycin Drugs Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Josamycin Tablets
5.2.2 Josamycin Propionate Granules
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital Pharmacy
6.2.2 Retail Drug Stores
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Josamycin Drugs Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Josamycin Drugs Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Josamycin Tablets
9.6.2 Josamycin Propionate Granules
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital Pharmacy
9.10.2 Retail Drug Stores
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Josamycin Tablets
10.6.2 Josamycin Propionate Granules
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital Pharmacy
10.10.2 Retail Drug Stores
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Josamycin Tablets
11.6.2 Josamycin Propionate Granules
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital Pharmacy
11.10.2 Retail Drug Stores
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Josamycin Tablets
12.6.2 Josamycin Propionate Granules
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital Pharmacy
12.10.2 Retail Drug Stores
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Josamycin Tablets
13.6.2 Josamycin Propionate Granules
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital Pharmacy
13.10.2 Retail Drug Stores
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Josamycin Drugs Market: Competitive Dashboard
14.2 Global Josamycin Drugs Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Astellas Pharma Inc.
14.3.2 Guanghua Pharmaceutical
14.3.3 Minsheng Pharmaceutical
14.3.4 Suzhou No.1 Pharm
14.3.5 Southwest Pharmaceutical
14.3.6 Wanbang Biopharmaceuticals
14.3.7 Bayer